Wall Street Wizardry
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Wall Street Wizardry

Investing

Ulytau Project Exploration Licence Granted

by admin March 19, 2025
March 19, 2025
Ulytau Project Exploration Licence Granted

C29 Metals (C29:AU) has announced Ulytau Project Exploration Licence Granted

Download the PDF here.

This post appeared first on investingnews.com

previous post
Presentation to Food and Ingredients China 2025 Conference
next post
Alvopetro Announces Year End 2024 Financial Results, Q1 2025 Dividend of US$0.10/share and Filing of our AIF

Related Posts

The Trader’s Flashlight in a Market Fog: What...

April 15, 2025

Top 5 Canadian Silver Stocks of 2025

April 14, 2025

Trump Ties Ukraine Aid to US$500 Billion in...

February 14, 2025

Asara Raises $2.3M in Placement to Underpin Exploration...

February 20, 2025

Editor’s Picks: Silver Price Sets New Record as...

December 13, 2025

$2million placement to advance Argentine exploration

November 7, 2025

Top 5 Canadian Biotech Stocks of 2025

July 25, 2025

Agriculture Market Forecast: Top Trends for Agriculture in...

January 24, 2025

Silver Miners Deliver Record Q2 Earnings as Price...

August 20, 2025

OPINION — Goldenomics 103: Gold Protects and Performs

August 16, 2025

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Universal’s ‘Wicked: For Good’ creates a unique marketing challenge

      January 26, 2025
    • 2

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 3

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 4

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 5

      Trump re-designates Iranian-backed Houthis as terrorists: ‘Threaten[s] security of American civilians’

      January 23, 2025
    • 6

      US security contractor will take charge of key checkpoint in Gaza as Israeli forces withdraw

      January 25, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • Terms and Conditions
    • Privacy Policy

    Disclaimer: wallstreetwizardry.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2026 wallstreetwizardry.com | All Rights Reserved